Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Progesterone Receptor Negative
- Acute Myeloid Leukemia
- Stage IIIC Esophageal Cancer
- Stage IV Soft Tissue Sarcoma
- Stage IVB Colon Cancer
- Stage IIIC Skin Melanoma
- Stage III Skin Melanoma
- Brain Glioblastoma
- Estrogen Receptor Negative
- Stage IIIA Skin Melanoma
- Stage III Ovarian Cancer
- Stage IIIA Gastric Cancer
- Stage IVA Bone Sarcoma
- Stage IV Non-small Cell Lung Cancer
- Stage IV Ovarian Cancer
- Stage IV Breast Cancer
- Stage IVA Rectal Cancer
- Triple-Negative Breast Carcinoma
- Stage IV Esophageal Cancer
- Stage IIIB Non Small Cell Lung Cancer
- Stage IV Bladder Cancer
- Stage IVB Rectal Cancer
- Stage IIB Rectal Cancer
- Stage IIC Rectal Cancer
- Stage IIIB Gastric Cancer
- Stage IIIB Rectal Cancer
- Stage III Gastric Cancer
- Stage II Rectal Cancer
- Stage IIIC Colon Cancer
- Stage IIIA Colon Cancer
- Stage IV Bone Sarcoma
- Stage IV Renal Cell Cancer
- Stage IIIC Gastric Cancer
- Stage IIB Pancreatic Cancer
- Stage III Non-Small Cell Lung Cancer
- Stage IIIC Ovarian Cancer
- Stage IIA Rectal Cancer
- Extensive Stage Small Cell Lung Carcinoma
- Head and Neck Carcinoma
- HER2/Neu Negative
- Hormone-Resistant Prostate Cancer
- Stage IIIA Esophageal Cancer
- Stage IIIA Rectal Cancer
- Stage IVB Bone Sarcoma
- Stage IIIA Ovarian Cancer
- Stage IV Colon Cancer
- Stage IIIB Esophageal Cancer
- Stage IIIC Rectal Cancer
- Stage IV Skin Melanoma
- Stage IIIA Non-Small Cell Lung Cancer
- Stage IIA Pancreatic Cancer
- Stage III Pancreatic Cancer
- Stage IV Pancreatic Cancer
- Stage III Colon Cancer
- Limited Stage Small Cell Lung Carcinoma
- Stage III Esophageal Cancer
- Stage IVA Colon Cancer
- Stage IIIB Colon Cancer
- Stage IV Gastric Cancer
- Stage III Rectal Cancer
- Recurrent Carcinoma
- Myelodysplastic Syndrome
- Progressive Disease
- Stage IIIB Ovarian Cancer
- Stage IIIB Skin Melanoma
- Stage IV Rectal Cancer
- Stage II Pancreatic Cancer
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
PRIMARY OBJECTIVES: I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities. SECONDARY OBJ...
PRIMARY OBJECTIVES: I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities. SECONDARY OBJECTIVES: I. To improve patients' experience of their care. II. Improve patient understanding of advanced care planning. III. To improve the receipt of goal concordant care. IV. To reduce total healthcare costs. OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients receive usual care. ARM B: Patients undergo health care coach support with a baseline introduction (either telephonic or in-person) of the program followed by a visit (telephonic or in-person) with the health care coach after the first oncology appointment to discuss goals of care. The health care coach will contact patient based on patients' ongoing needs (weekly to monthly) and will conduct symptom assessments based on patients' treatment plans and symptoms. After completion of study, patients are followed up for 6 months.
Tracking Information
- NCT #
- NCT03154190
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Manali Patel Stanford University
Get Well Soon